What type of study is this?

This is a Literature Review study.

Cardiotoxicity of Targeted Therapies in Non-Hematologic Cancers: Mechanisms, Risks and Monitoring

View Full Paper

Ask AI

Bookmark

Authors

Review highlights risks and mechanisms of cardiotoxicity in targeted therapies, emphasizing early monitoring.

Cardiotoxicity from targeted therapies greatly affects cancer survivors, compromising their long-term health.
Adverse cardiovascular events include left ventricular dysfunction, hypertension, and arrhythmias, complicating cancer care.
Patient-specific characteristics, like age and preexisting cardiovascular disease, significantly influence cardiotoxicity risk.
A multidisciplinary approach is essential for detecting and managing treatment-related cardiotoxicity among cancer patients.

Habbal et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark